C T Brown
Overview
Explore the profile of C T Brown including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Saher Helmy A, Hutchings D, Kleckner T, Marsh J, Bryce A, Arnold J, et al.
Opt Lett
. 2007 Dec;
25(18):1370-2.
PMID: 18066220
We report the observation of second-harmonic generation by type I quasi phase matching in a GaAs-AlAs superlattice waveguide. Quasi phase matching was achieved through modulation of the nonlinear coefficient chi((2))(zxy),...
12.
Rafailov E, Loza-Alvarez P, Brown C, Sibbett W, De La Rue R, Millar P, et al.
Opt Lett
. 2007 Dec;
26(24):1984-6.
PMID: 18059753
We demonstrate, for the first time to our knowledge, the generation of second-harmonic pulses by use of a novel methodology for achieving first-order quasi-phase matching in a semiconductor waveguide crystal....
13.
Yap T, Brown C, Emberton M
World J Urol
. 2006 May;
24(4):371-7.
PMID: 16685521
The standard treatments for men with lower urinary tract symptoms (LUTS) range from watchful waiting to medical and finally surgical intervention. However, the role of self-management interventions such as education...
14.
Wazait H, van der Meullen J, Patel H, Brown C, Gadgil S, Miller R, et al.
J Hosp Infect
. 2004 Nov;
58(4):297-302.
PMID: 15564006
Globally, millions of patients undergo urethral catheterization every year. Our objective was to study the current use of prophylactic antibiotics on urinary catheter withdrawal. A questionnaire (N = 300) was...
15.
Watson V, Ryan M, Brown C, Barnett G, Ellis B, Emberton M
J Urol
. 2004 Nov;
172(6 Pt 1):2321-5.
PMID: 15538258
Purpose: There are 2 main medical preparations available for lower urinary tract symptoms resulting from benign prostatic hyperplasia (BPH). Choosing between an alpha-blocker and a 5alpha-reductase inhibitor requires trade-offs between...
16.
Brown C, Callan Jr C
Proc Natl Acad Sci U S A
. 2004 Feb;
101(8):2404-9.
PMID: 14983022
The cAMP response protein (CRP) is a transcription factor known to regulate many genes in Escherichia coli. Computational studies of transcription factor binding to DNA are usually based on a...
17.
Irani J, Brown C, van der Meulen J, Emberton M
BJU Int
. 2003 Nov;
92(9):937-42.
PMID: 14632851
Objective: To compare overall and methodological quality with content in national and supra-national Clinical Practice Guidelines (CPGs) on benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), as the...
18.
Brown C, Nuttall M
Int J Clin Pract
. 2003 Nov;
57(8):705-9.
PMID: 14627182
Dutasteride is a new 5-alpha reductase inhibitor for the treatment of men with moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. It has been available in...
19.
Brown C, van der Meulen J, Mundy A, Emberton M
BJU Int
. 2003 Jun;
92(1):53-7.
PMID: 12823383
Objective: To determine the use of lifestyle and behavioural interventions in the UK for symptom control in men with uncomplicated lower urinary tract symptoms (LUTS) on watchful waiting (WW). Method:...
20.
Brown C, OFlynn E, van der Meulen J, Newman S, Mundy A, Emberton M
BJU Int
. 2003 Mar;
91(1):30-2.
PMID: 12614245
Objective: To explore the concerns and worries in men with uncomplicated lower urinary tract symptoms (LUTS, but no evidence of prostate cancer) relating to their symptoms. Patients And Methods: There...